Dow's Nearly 150-Point Drop Led By Losses For Nike, Merck Shares

Dow Jones2025-06-18

DJ Dow's Nearly 150-Point Drop Led By Losses For Nike, Merck Shares

This article was automatically generated by MarketWatch using technology from Automated Insights.

Dragged down by declines for shares of Nike and Merck, the Dow Jones Industrial Average is falling Tuesday afternoon.

The Dow (Dow Jones Industrial Average) was most recently trading 148 points (0.3%) lower, as shares of Nike (Nike Inc. Cl B) and Merck (Merck & Co. Inc.) have contributed to the blue-chip gauge's intraday decline.

Nike's shares have declined $1.44 (2.3%) while those of Merck are down $1.84, or 2.3%, combining for a roughly 20-point drag on the Dow.

Also contributing significantly to the decline are Amgen (Amgen Inc.), Verizon (Verizon Communications Inc.), and Johnson & Johnson (Johnson & Johnson).

A $1 move in any one of the 30 components of the index results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 17, 2025 13:07 ET (17:07 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment